Evidence map›Paper›PMID 20622020›Full record

ArticleThe Journal of biological chemistry2010

Complex role of collybistin and gephyrin in GABAA receptor clustering.

Leila Saiepour, Celine Fuchs, Annarita Patrizi, Marco Sassoè-Pognetto, Robert J Harvey, Kirsten Harvey

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 135 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Impaired axon initial segment structure and function in a model ofProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Modular Structure and Polymerization Status of GABAInternational journal of molecular sciences · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. A novelThe Journal of international medical research · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Effects of GABAFrontiers in molecular neuroscience · 2020
    Article
  18. Article
  19. Review
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Leila SaiepourDepartment of Pharmacology, The School of Pharmacy, University of London, 29-39 Brunswick Square, London WC1N 1AX, United Kingdom.
Celine Fuchs
Annarita Patrizi
Marco Sassoè-Pognetto
Robert J Harvey
Kirsten Harvey
Medway School of Pharmacy · GBNeuroscience Institute · ITUniversity of London · GBUniversity of Turin · IT

Funding

Medical Research Council G0501258Medical Research Council G0800498
6 · The paper itself

Abstract

Gephyrin and collybistin are key components of GABA(A) receptor (GABA(A)R) clustering. Nonetheless, resolving the molecular interactions between the plethora of GABA(A)R subunits and these clustering proteins is a significant challenge. We report a direct interaction of GABA(A)R α2 and α3 subunit intracellular M3-M4 domain (but not α1, α4, α5, α6, β1-3, or γ1-3) with gephyrin. Curiously, GABA(A)R α2, but not α3, binds to both gephyrin and collybistin using overlapping sites. The reciprocal binding sites on gephyrin for collybistin and GABA(A)R α2 also overlap at the start of the gephyrin E domain. This suggests that although GABA(A)R α3 interacts with gephyrin, GABA(A)R α2, collybistin, and gephyrin form a trimeric complex. In support of this proposal, tri-hybrid interactions between GABA(A)R α2 and collybistin or GABA(A)R α2 and gephyrin are strengthened in the presence of gephyrin or collybistin, respectively. Collybistin and gephyrin also compete for binding to GABA(A)R α2 in co-immunoprecipitation experiments and co-localize in transfected cells in both intracellular and submembrane aggregates. Interestingly, GABA(A)R α2 is capable of "activating " collybistin isoforms harboring the regulatory SH3 domain, enabling targeting of gephyrin to the submembrane aggregates. The GABA(A)R α2-collybistin interaction was disrupted by a pathogenic mutation in the collybistin SH3 domain (p.G55A) that causes X-linked intellectual disability and seizures by disrupting GABA(A)R and gephyrin clustering. Because immunohistochemistry in retina revealed a preferential co-localization of collybistin with α2 subunit containing GABA(A)Rs, but not GlyRs or other GABA(A)R subtypes, we propose that the collybistin-gephyrin complex has an intimate role in the clustering of GABA(A)Rs containing the α2 subunit.

Indexed as

Blotting, WesternCarrier ProteinsCell LineGuanine Nucleotide Exchange FactorsHumansImmunohistochemistryImmunoprecipitationMembrane ProteinsMicroscopy, ConfocalModels, BiologicalMutagenesis, Site-DirectedProtein BindingReceptors, GABA-ARho Guanine Nucleotide Exchange FactorsTwo-Hybrid System TechniquesARHGEF9 protein, humanCarrier ProteinsgephyrinGuanine Nucleotide Exchange FactorsMembrane ProteinsReceptors, GABA-ARho Guanine Nucleotide Exchange Factors

Identifiers

PMID20622020
PMCPMC2937993
OpenAlexW2163881043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.